Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

696 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CT screening for COVID-19 in asymptomatic patients before hospital admission.
Uchida S, Uno S, Uwamino Y, Hashimoto M, Matsumoto S, Obara H, Jinzaki M, Kitagawa Y, Hasegawa N; Keio Donner Project Team. Uchida S, et al. Among authors: uno s. J Infect Chemother. 2021 Feb;27(2):232-236. doi: 10.1016/j.jiac.2020.09.025. Epub 2020 Sep 29. J Infect Chemother. 2021. PMID: 33172767 Free PMC article.
Control of a Nosocomial Outbreak of COVID-19 in a University Hospital.
Harada S, Uno S, Ando T, Iida M, Takano Y, Ishibashi Y, Uwamino Y, Nishimura T, Takeda A, Uchida S, Hirata A, Sata M, Matsumoto M, Takeuchi A, Obara H, Yokoyama H, Fukunaga K, Amagai M, Kitagawa Y, Takebayashi T, Hasegawa N. Harada S, et al. Among authors: uno s. Open Forum Infect Dis. 2020 Oct 22;7(12):ofaa512. doi: 10.1093/ofid/ofaa512. eCollection 2020 Dec. Open Forum Infect Dis. 2020. PMID: 33330740 Free PMC article.
Identification of B.1.346 Lineage of SARS-CoV-2 in Japan: Genomic Evidence of Re-entry of Clade 20C.
Abe K, Shimura T, Takenouchi T, Iwasaki YW, Ishizu H, Uwamino Y, Uno S, Gotoh J, Tachikawa N, Takeuchi Y, Katayama J, Nozaki H, Fujii S, Seki S, Nakamura M, Uda K, Misumi T, Ishihara J, Yamada K, Kanai T, Murai S, Araki K, Ebihara T, Siomi H, Hasegawa N, Kitagawa Y, Amagai M, Suematsu M, Kosaki K. Abe K, et al. Among authors: uno s. Keio J Med. 2021 Jun 25;70(2):44-50. doi: 10.2302/kjm.2021-0005-OA. Epub 2021 Apr 14. Keio J Med. 2021. PMID: 33853975 Free article.
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan.
Nishimura T, Uwamino Y, Uno S, Kashimura S, Shiraki T, Kurafuji T, Morita M, Noguchi M, Azegami T, Yamada-Goto N, Murai-Takeda A, Yokoyama H, Kuwabara K, Kato S, Matsumoto M, Hirata A, Iida M, Harada S, Ishizaka T, Misawa K, Murata M, Saya H, Amagai M, Kitagawa Y, Takeuchi T, Mori M, Takebayashi T, Hasegawa N; Keio Donner Project Team. Nishimura T, et al. Among authors: uno s. Intern Med. 2021 Aug 15;60(16):2569-2575. doi: 10.2169/internalmedicine.7033-21. Epub 2021 Jun 19. Intern Med. 2021. PMID: 34148952 Free PMC article.
Clinical Utility of SARS-CoV-2 Whole Genome Sequencing in Deciphering Source of Infection.
Takenouchi T, Iwasaki YW, Harada S, Ishizu H, Uwamino Y, Uno S, Osada A, Abe K, Hasegawa N, Murata M, Takebayashi T, Fukunaga K, Saya H, Kitagawa Y, Amagai M, Siomi H, Kosaki K; Keio Donner Project. Takenouchi T, et al. Among authors: uno s. J Hosp Infect. 2020 Oct 24;107:40-4. doi: 10.1016/j.jhin.2020.10.014. Online ahead of print. J Hosp Infect. 2020. PMID: 34756867 Free PMC article.
Pro108Ser mutation of SARS-CoV-2 3CLpro reduces the enzyme activity and ameliorates the clinical severity of COVID-19.
Abe K, Kabe Y, Uchiyama S, Iwasaki YW, Ishizu H, Uwamino Y, Takenouchi T, Uno S, Ishii M, Maruno T, Noda M, Murata M, Hasegawa N, Saya H, Kitagawa Y, Fukunaga K, Amagai M, Siomi H, Suematsu M, Kosaki K; Keio Donner Project. Abe K, et al. Among authors: uno s. Sci Rep. 2022 Jan 25;12(1):1299. doi: 10.1038/s41598-022-05424-3. Sci Rep. 2022. PMID: 35079088 Free PMC article.
696 results